13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001104659-23-118127
Total Value
$949.9M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 8,493,321 | $180.9M | 19.04% |
| 2 | RAYZEBIO INC | 75525N107 | 4,016,847 | $89.2M | 9.39% |
| 3 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,082,622 | $47.3M | 4.98% |
| 4 | COGENT BIOSCIENCES INC | COGT | 4,684,167 | $45.7M | 4.81% |
| 5 | TAYSHA GENE THERAPIES INC | TSHA | 14,444,444 | $45.6M | 4.80% |
| 6 | MERUS N V | N5749R100 | 1,726,214 | $40.7M | 4.28% |
| 7 | ENLIVEN THERAPEUTICS INC | ELVN | 2,954,902 | $40.4M | 4.25% |
| 8 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,000,000 | $38.2M | 4.02% |
| 9 | PHARVARIS N V | PHVS | 1,563,513 | $32.6M | 3.43% |
| 10 | CABALETTA BIO INC | CABA | 1,973,253 | $30.0M | 3.16% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 2,916,667 | $28.1M | 2.96% |
| 12 | GH RESEARCH PLC | GHRS | 2,744,125 | $27.6M | 2.90% |
| 13 | HILLEVAX INC | 43157M102 | 2,037,313 | $27.4M | 2.88% |
| 14 | SAVARA INC | SVRA | 7,184,865 | $27.2M | 2.86% |
| 15 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,090,000 | $25.0M | 2.63% |
| 16 | AMBRX BIOPHARMA INC | 02290A102 | 2,070,000 | $23.8M | 2.51% |
| 17 | TRAVERE THERAPEUTICS INC | TVTX | 2,623,677 | $23.5M | 2.47% |
| 18 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $19.5M | 2.05% |
| 19 | CELCUITY INC | CELC | 2,105,386 | $19.2M | 2.03% |
| 20 | TERNS PHARMACEUTICALS INC | TERN | 3,092,273 | $15.6M | 1.64% |
| 21 | MERSANA THERAPEUTICS INC | 59045L106 | 11,328,000 | $14.4M | 1.51% |
| 22 | APPLIED THERAPEUTICS INC | 03828A101 | 5,658,034 | $14.1M | 1.48% |
| 23 | ORIC PHARMACEUTICALS INC | ORIC | 2,142,856 | $13.0M | 1.36% |
| 24 | DIANTHUS THERAPEUTICS INC | DNTH | 927,706 | $12.7M | 1.33% |
| 25 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 6,573,300 | $9.9M | 1.04% |
| 26 | PRAXIS PRECISION MEDICINES I | PRAX | 5,304,410 | $9.1M | 0.95% |
| 27 | ACELYRIN INC | 00445A100 | 864,332 | $8.8M | 0.93% |
| 28 | TREVI THERAPEUTICS INC | TRVI | 3,422,397 | $7.5M | 0.79% |
| 29 | ACLARIS THERAPEUTICS INC | ACRS | 1,040,754 | $7.1M | 0.75% |
| 30 | MILESTONE PHARMACEUTICALS IN | MIST | 2,208,812 | $6.8M | 0.72% |
| 31 | PLIANT THERAPEUTICS INC | PLRX | 288,949 | $5.0M | 0.53% |
| 32 | SAGIMET BIOSCIENCES INC | SGMT | 515,000 | $4.5M | 0.48% |
| 33 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 295,034 | $3.6M | 0.38% |
| 34 | LYRA THERAPEUTICS INC | LYRA | 924,170 | $3.6M | 0.38% |
| 35 | OLEMA PHARMACEUTICALS INC | OLMA | 77,042 | $951,469 | 0.10% |
| 36 | RALLYBIO CORP | RLYB | 268,532 | $904,953 | 0.10% |
| 37 | AFFIMED N V | N01045108 | 1,428,571 | $682,714 | 0.07% |